VCA-894A for charcot-marie-tooth disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 13 May 2025: Trial started, NCT07223632
  2. 3 Nov 2025: Trial registered, NCT07223632

The trials

NCT07223632: Treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S) in an Individual Patient

State
Under way
Phase
Phase 1 and Phase 2
People
1 taking part
Started
13 May 2025
Primary completion
Mar 2027
Arms
VCA-894A
Results
None posted
  1. 13 May 2025: Trial started
  2. 3 Nov 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.